• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective.

作者信息

Humbert Marc, Lau Edmund M T

机构信息

Service de Pneumologie et Soins Intensifs Respiratoires Hôpital Bicêtre (Assistance Publique Hôpitaux de Paris) Le Kremlin Bicêtre, France.

Faculté de Medicine Université Paris-Saclay Le Kremlin-Bicêtre, France.

出版信息

Am J Respir Crit Care Med. 2021 Mar 15;203(6):675-677. doi: 10.1164/rccm.202012-4350ED.

DOI:10.1164/rccm.202012-4350ED
PMID:33357026
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7958524/
Abstract
摘要

相似文献

1
Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective.肺动脉高压的风险分层：不要忘记患者的视角。
Am J Respir Crit Care Med. 2021 Mar 15;203(6):675-677. doi: 10.1164/rccm.202012-4350ED.
2
Pulmonary arterial hypertension registries: past, present and into the future.肺动脉高压登记研究：过去、现在和未来。
Eur Respir Rev. 2019 Dec 18;28(154). doi: 10.1183/16000617.0128-2019. Print 2019 Dec 31.
3
Call it by the correct name-pulmonary hypertension not pulmonary arterial hypertension: growing recognition of the global health impact for a well-recognized condition and the role of the Pulmonary Vascular Research Institute.用正确的名称称呼它——肺动脉高压而非动脉性肺动脉高压：对一种广为人知的疾病的全球健康影响以及肺血管研究所的作用的认识不断提高。
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L992-L994. doi: 10.1152/ajplung.00098.2020. Epub 2020 Apr 1.
4
The Clinical Value of Proposed Risk Stratification Tools in Pediatric Pulmonary Arterial Hypertension.拟议的风险分层工具在儿童肺动脉高压中的临床价值
Am J Respir Crit Care Med. 2019 Nov 15;200(10):1312-1315. doi: 10.1164/rccm.201902-0266LE.
5
[Heritable pulmonary arterial hypertension].[遗传性肺动脉高压]
Inn Med (Heidelb). 2024 Jun;65(6):560-565. doi: 10.1007/s00108-024-01718-y. Epub 2024 May 21.
6
Schistosomiasis-associated pulmonary arterial hypertension: a systematic review.血吸虫病相关肺动脉高压：系统评价。
Eur Respir Rev. 2020 Feb 5;29(155). doi: 10.1183/16000617.0089-2019. Print 2020 Mar 31.
7
Mixed Venous Oxygen Saturation Is a Better Prognosticator Than Cardiac Index in Pulmonary Arterial Hypertension.混合静脉血氧饱和度比心指数更能预测肺动脉高压的预后。
Chest. 2020 Dec;158(6):2546-2555. doi: 10.1016/j.chest.2020.06.053. Epub 2020 Jul 3.
8
Enhanced Pulmonary Artery Radiodensity in Pulmonary Arterial Hypertension: A Sign of Early Calcification?肺动脉高压中肺动脉放射性密度增强：早期钙化的迹象？
Am J Respir Crit Care Med. 2019 Mar 15;199(6):799-802. doi: 10.1164/rccm.201806-1027LE.
9
Evaluation and management of pulmonary arterial hypertension.肺动脉高压的评估与管理。
Respir Med. 2020 Sep;171:106099. doi: 10.1016/j.rmed.2020.106099. Epub 2020 Aug 19.
10
Idiopathic pulmonary arterial hypertension with coexisting CHD.特发性肺动脉高压合并冠心病
Cardiol Young. 2018 May;28(5):743-746. doi: 10.1017/S1047951117002876. Epub 2018 Jan 10.

引用本文的文献

1
Individually Tailored Remote Physiotherapy Program Improves Participation and Autonomy in Activities of Everyday Life along with Exercise Capacity, Self-Efficacy, and Low-Moderate Physical Activity in Patients with Pulmonary Arterial Hypertension: A Randomized Controlled Study.个体化远程物理治疗方案可改善肺动脉高压患者的日常活动参与度和自主性、运动能力、自我效能感和中低强度体力活动：一项随机对照研究。
Medicina (Kaunas). 2022 May 14;58(5):662. doi: 10.3390/medicina58050662.

本文引用的文献

1
EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR.EmPHasis-10 作为肺动脉高压患者健康相关生活质量的衡量指标：来自 PHAR 的研究数据。
Eur Respir J. 2021 Feb 25;57(2). doi: 10.1183/13993003.00414-2020. Print 2021 Feb.
2
Prediction of Health-related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.肺动脉高压患者健康相关生活质量及住院情况的预测：肺动脉高压协会注册研究
Am J Respir Crit Care Med. 2021 Mar 15;203(6):761-764. doi: 10.1164/rccm.202010-3967LE.
3
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study.EmPHasis-10 与健康相关的生活质量评分可预测特发性和结缔组织病相关肺动脉高压患者的结局：来自英国多中心研究的结果。
Eur Respir J. 2021 Feb 25;57(2). doi: 10.1183/13993003.00124-2020. Print 2021 Feb.
4
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.预测肺动脉高压患者的生存情况：REVEAL 风险评分计算器 2.0 与 ESC/ERS 风险评估策略的比较。
Chest. 2019 Aug;156(2):323-337. doi: 10.1016/j.chest.2019.02.004. Epub 2019 Feb 14.
5
The importance of patient perspectives in pulmonary hypertension.患者视角在肺动脉高压中的重要性。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01919-2018. Print 2019 Jan.
6
Risk stratification and medical therapy of pulmonary arterial hypertension.肺动脉高压的风险分层与药物治疗。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01889-2018. Print 2019 Jan.
7
Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial.肺动脉高压症状和影响问卷（PAH-SYMPACT）的心理测量学验证：SYMPHONY 试验结果。
Chest. 2018 Oct;154(4):848-861. doi: 10.1016/j.chest.2018.04.027. Epub 2018 Apr 26.
8
Risk assessment in pulmonary arterial hypertension.肺动脉高压的风险评估
Eur Respir J. 2018 Mar 29;51(3). doi: 10.1183/13993003.00279-2018. Print 2018 Mar.
9
Risk assessment in pulmonary arterial hypertension.肺动脉高压的风险评估
Eur Respir J. 2018 Mar 29;51(3). doi: 10.1183/13993003.02606-2017. Print 2018 Mar.
10
Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.肺动脉高压相关发病率是死亡率的预后因素。
J Am Coll Cardiol. 2018 Feb 20;71(7):752-763. doi: 10.1016/j.jacc.2017.12.010.